PaulMMcKieMD

Cardiology • Rochester, MN

Heart Failure & Transplantation, Preventive Cardiology

Assistant Professor of Medicine

Join to view full profile

Dr. McKie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McKie's full profile

Already have an account?

Office
200 1st Street SW
Rochester, MN 55905

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2013 - 2014
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2009 - 2013
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Geisel School of Medicine at DartmouthClass of 2006

Certifications & Licensure

IA State Medical License 2015 - 2026
MN State Medical License 2007 - 2025
WI State Medical License 2014 - 2025
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
National Board of EchocardiographyASCeXAM Certification

Awards, Honors, & Recognition

American Society of Hypertension Young Investigator Award 2011
Mayo Clinic Dept of Medicine Outstanding Research Fellow Award 2011
American College of Cardiology Merck Fellowship Award 2010
Douglas P Zipes Cardiovascular Research Prize in Medicine 2006
Stanley J Sarnoff Cardiovascular Research Fellowship 2004
Join now to see all

Clinical Trials

Impact of MayoExpertAdvisor on Provider Adherence Start of enrollment: 2016 Apr 01
Completed
Not Applicable
Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome Start of enrollment: 2017 Jan 01
Enrolling by invitation
Phase 1
MANP in Hypertension and Metabolic Syndrome Start of enrollment: 2017 Aug 18
Completed
Phase 1
MANP in African Americans With Hypertension Start of enrollment: 2018 May 01
Withdrawn
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

28 citations
Biomarker-based risk prediction in the community.
Omar F. AbouEzzeddine, Paul M. McKie, Christopher G. Scott, Richard J. Rodeheffer, Horng H. Chen
European Journal of Heart Failure. 2016-11-01
44 citations
High-Sensitivity Troponin I and Amino-Terminal Pro-B–Type Natriuretic Peptide Predict Heart Failure and Mortality in the General Population
Paul M. McKie, Omar F. AbouEzzeddine, Christopher G. Scott, Ramila A. Mehta, Richard J. Rodeheffer
Clinical Chemistry. 2014-09-01
119 citations
Defining High-Sensitivity Cardiac Troponin Concentrations in the Community
Paul M. McKie, Denise M. Heublein, Christopher G. Scott, Mary Lou Gantzer, Ramila A. Mehta
Clinical Chemistry. 2013-07-01

Lectures

Clinical Pearls: Cardiology and Pulmonary Medicine
2019 ACP Internal Medicine Meeting, Philadelphia - 4/11/2019

Authored Content

Hemodynamic Factors Associated with Serum Chloride in Ambulatory Patients with Advanced Heart FailureDecember 2017

Press Mentions

Cardiac Stress Test Is Important ToolFebruary 24th, 2020
#MayoClinicRadio Podcast: 5/4/19May 6th, 2019
When to Transition Heart Failure Patient to Alternative Loop DiureticApril 22nd, 2019
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member
American Medical Association - AMA
Member
Heart Failure Society of America
Member